BackNatureWise Biotech & Medicals Overview

NatureWise Biotech & Medicals Total Liabilities

Latest total liabilities for 4732.TWO: $92M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$91.80M
↑ 34.88% YoYΔ $23.74M vs prior year quarter

Peer trimmed avg / median

Loading

NatureWise Biotech & Medicals Total Liabilities History

Loading

NatureWise Biotech & Medicals vs. peers: Total Liabilities Comparison

Loading

NatureWise Biotech & Medicals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NatureWise Biotech & Medicals (4732.TWO) FAQ

The latest total liabilities for 4732.TWO is $92M as of June 2026. That compares with $68M in the prior-year period — up 34.9% year over year. Investors often review this figure alongside NatureWise Biotech & Medicals's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4732.TWO's total liabilities moved from $68M to $92M — a 34.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NatureWise Biotech & Medicals's operating scale or balance-sheet position.

A total liabilities figure of $92M for 4732.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4732.TWO's total liabilities ($92M), review year-over-year change from $68M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NatureWise Biotech & Medicals's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.